Granted Patent
B2
US 10,822,380 · App. 15/565,229 · Granted Nov 3, 2020
Disruption of the WAVE3 protein complex for suppression of invasion and metastasis
Assignees:
University of Georgia Research Foundation, Inc.; Augusta University Research Institute, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
As disclosed herein, stapled peptides targeting the interaction interface between proteins that maintain the integrity of Wiskott-Aldrich syndrome protein family member 3 (WASF3) leads to destabilization of WASF3 and suppression of invasion. Disclosed are stapled peptides that inhibit the binding of Cytoplasmic FMR1-interacting protein 1 (CYFIP1) to either WASF3 or NCK-associated protein (NCKAP1). Also disclosed are methods for treating or suppressing invasion and metastasis of a cancer in a subject that involve administering to the subject a therapeutically effective amount of a stapled peptide disclosed herein.
Claims (1)
1. A synthetic polypeptide, comprising an amino acid sequence that comprises SEQ ID NO: 1 or SEQ ID NO: 2.
Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 9, 2018
From: COWELL, JOHN
To: THE BOARD OF REGENTS OF THE UNIVERSITY SYSTEM OF GEORGIA ON BEHALF OF AUGUSTA UNIVERSITY
Reel/Frame 045156/0263 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 9, 2018
From: KENNEDY, EILEEN J.
To: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
Reel/Frame 045156/0309 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 9, 2018
From: THE BOARD OF REGENTS OF THE UNIVERSITY SYSTEM OF GEORGIA ON BEHALF OF AUGUSTA UNIVERSITY
To: AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.
Reel/Frame 045156/0387 →
CONFIRMATORY LICENSE
Recorded Jan 30, 2018
From: UNIVERSITY OF GEORGIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045194/0668 →
Continuity (2)
Provisional Application
62144631
· Apr 8, 2015